H. Takahashi et al., CHARACTERIZATION OF THE HEPATIC CANALICULAR MEMBRANE-TRANSPORT OF A MODEL OLIGOPEPTIDE - DITEKIREN, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 297-303
Many small oligopeptides are rapidly excreted unchanged into bile, whi
ch requires vectorial transport across the hepatocyte. To characterize
the involved carrier system(s) at the canalicular membrane, studies w
ere undertaken with vesicle preparations from the rat and the model ps
eudohexapeptide ditekiren. The initial uptake rate into inside-out-ori
ented vesicles was found to be ATP- and temperature-dependent and satu
rable. Kinetic analysis indicated the involvement of three processes:
(1) an ATF-dependent carrier-mediated process (K-m = 19.1 +/- 4.26 mu
M; mean +/- S.E.M.), V-max = 140 +/- 29.4 pmol/mg of protein/15 sec),
(2) an ATF-independent carrier-mediated transporter (K-m = 17.2 +/- 9.
58 mu M, V-max = 62.9 +/- 24.5 pmol/mg of protein/15 sec) and (3) a no
nsaturable component. ATF-dependent uptake was inhibited by several ot
her oligopeptides, which in the case of EMD 51921 was competitive. Cis
-inhibition studies with known substrates for the canalicular bile sal
t (taurocholate), multispecific organic anion (glutathione disulfide)
and P-glycoprotein (daunomycin, nicardipine, cyclosporin A) transporte
rs indicated a major role for the latter carrier system. Inhibition of
the initial uptake rate of ditekiren by daunomycin was found to be co
mpetitive in nature (K-i = 16 mu M). These findings indicate that the
biliary excretion of ditekiren and possibly other hydrophobic oligopep
tides is mediated, in part, by P-glycoprotein and suggest a possible p
hysiological role for this hepatic transporter.